Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tjønnfjord

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bone Marrow Transplantation|July 1, 2008
High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCTA Kolstad, G Tjønnfjord, V Jønsson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 30, 1990
[Folic acid deficiency can cause severe anemia and pancytopenia]L Brinch, G Tjønnfjord, B Ly
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1988
[Pseudothrombocytopenia]G Tjønnfjord, S A Evensen, R Nordhagen
Journal of Internal Medicine|November 1, 1992
Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapyS A Evensen, L Brinch, P Stavem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1995
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factorG Juliusson, R Lenkei, G Tjønnfjord, et al.
Transplantation Proceedings|February 1, 1993
Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantationT Egeland, G Tjønnfjord, R Steen, et al.
British Journal of Haematology|March 1, 1995
Low-dose cladribine for symptomatic hairy cell leukaemiaG Juliusson, R Lenkei, G Tjønnfjord, et al.
Stem Cells (Dayton, Ohio)|September 29, 2000
New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patientsO Bruserud, G Tjønnfjord, B T Gjertsen, et al.
British Journal of Haematology|September 1, 1994
Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemiaS A Evensen, L Brinch, G Tjønnfjord, et al.
Clinical and Experimental Immunology|June 1, 2006
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropeniaA M Holm, G Tjønnfjord, A Yndestad, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bone Marrow Transplantation|July 1, 2008
High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCTA Kolstad, G Tjønnfjord, V Jønsson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 30, 1990
[Folic acid deficiency can cause severe anemia and pancytopenia]L Brinch, G Tjønnfjord, B Ly
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1988
[Pseudothrombocytopenia]G Tjønnfjord, S A Evensen, R Nordhagen
Journal of Internal Medicine|November 1, 1992
Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapyS A Evensen, L Brinch, P Stavem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1995
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factorG Juliusson, R Lenkei, G Tjønnfjord, et al.
Transplantation Proceedings|February 1, 1993
Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantationT Egeland, G Tjønnfjord, R Steen, et al.
British Journal of Haematology|March 1, 1995
Low-dose cladribine for symptomatic hairy cell leukaemiaG Juliusson, R Lenkei, G Tjønnfjord, et al.
Stem Cells (Dayton, Ohio)|September 29, 2000
New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patientsO Bruserud, G Tjønnfjord, B T Gjertsen, et al.
British Journal of Haematology|September 1, 1994
Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemiaS A Evensen, L Brinch, G Tjønnfjord, et al.
Clinical and Experimental Immunology|June 1, 2006
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropeniaA M Holm, G Tjønnfjord, A Yndestad, et al.
Pageof 2